Article citationsMore>>

Megino-Luque, C., Moiola, C.P., Molins-Escuder, C., López-Gil, C., Gil-Moreno, A., Matias-Guiu, X., et al. (2020) Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer. Cancers, 12, Article 2751.
https://doi.org/10.3390/cancers12102751

has been cited by the following article:

• TITLE: Plastic Surgery Update on Epigenetic Reprogramming of Aging (ERA): Mechanisms, Pathways and Strategies toward Cell-Free Aesthetic Rejuvenating Applications

  AUTHORS: Gordon Hiroshi Sasaki

  KEYWORDS: Partial Epigenetic Reprogramming, Skin Rejuvenation, Aging Skin

  JOURNAL NAME: Open Access Library Journal, Vol.12 No.7, July 15, 2025

  ABSTRACT: Epigenetics can be defined as a heritable or reversible change in gene expression that is not accompanied by changes in DNA sequences. Epigenetics provides an additional layer of instructions that can affect where and when genes are expressed, modulating the aging process in response to an array of environmental factors such as diet, lifestyle, genetics and disease. Subsequent changes at the gene level are likely to contribute to cell, organ and body senescence affecting the health and well-being of patients. In recent years, regenerative aesthetic medicine has been integrated in the management of aging skin to either replace or restore damaged and dysfunctional skin cells to acquire more youthful appearance and function. In the past decade, small molecule-based pre-clinical studies are investigating partial epigenetic reprogramming intervention strategies for epigenetic rejuvenation to reduce or reverse these infirmities through modifications of epigenetic marks and gene expression patterns.